Catalog Number UNK ABSOLUTE PRO |
Device Problem
Failure to Advance (2524)
|
Patient Problems
Myocardial Infarction (1969); Renal Failure (2041); Perforation of Vessels (2135); Stenosis (2263); Obstruction/Occlusion (2422); Respiratory Failure (2484); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
|
Event Date 12/01/2020 |
Event Type
Injury
|
Event Description
|
It was reported through the pmcf report, that the absolute pro.035 stent may be related to the adverse patient effects of death, myocardial infarction, pulmonary complications, renal complications, access site complications, thrombosis, embolization, dissection, perforation, occlusion, re-stenosis, revascularization, unplanned amputation / surgical intervention, re-hospitalization and the device malfunction of failure to cross.Details are listed in the attached report, titled post-market clinical follow-up evaluation report peripheral self-expanding stents please see the attached post market clinical follow up evaluation report for specific information.
|
|
Manufacturer Narrative
|
B3: date of event is estimated.D4: the udi is unknown due to the part/lot number was not provided.D6: date of implant is estimated.The device was not returned for evaluation.A review of the lot history record could not be conducted because the part and lot number was not provided.The investigation determined a conclusive cause for the reported failure to advance cannot be determined.The reported patient effect(s) of embolization, myocardial infarction, renal failure, restenosis, thrombosis, occlusion, vessel dissection, vessel perforation and surgical intervention are listed in the absolute pro vascular self-expanding stent system instructions for use as potential adverse effect (e.G., complications) that may be associated with the use of the device.A conclusive cause for the reported respiratory failure, renal failure, stenosis, embolism / embolus, vascular dissection, perforation of vessels, obstruction/ occlusion, thrombosis/ thrombus, myocardial infarction, unspecified tissue injury and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effect of death reported in the report is captured under separate medwatch report.As multiple devices were captured in the pmcf report, additional reports were filed under manufacturing reference numbers cn-164112.Pmcf attachment rpt2131801 rev c titled: post-market clinical follow-up evaluation report peripheral self-expanding stentsna.
|
|
Search Alerts/Recalls
|
|